Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation

Biochemical and Biophysical Research Communications

Volumn 402, Issue 4, 2010, Pages 631-636

  Kim, Rae Kwon ^a   Yoon, Chang Hwan ^a   Hyun, Kyung Hwan ^a   Lee, Hyejin ^a   An, Sungkwan ^b   Park, Myung Jin ^c   Kim, Min Jung ^a   Lee, Su Jae ^a  

^a Hanyang University   (South Korea)

^b Konkuk University   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Fractionated radiation; Glioma stem like cells; LCK; Resistance to anticancer treatments

Indexed keywords

CD133 ANTIGEN; CELL PROTEIN; CISPLATIN; ETOPOSIDE; MUSASHI PROTEIN; NESTIN; NOTCH2 RECEPTOR; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL EXPANSION; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GAMMA IRRADIATION; GENE INACTIVATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS;

BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; RNA, SMALL INTERFERING;

EID: 78649446893     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.072     Document Type: Article

References (28)

1. Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., Terzis A.J. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat. Rev. Cancer 2005, 5:899-904.
2. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
3. Li F., Tiede B., Massague J., Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2007, 17:3-14.
4. Eramo A., Ricci-Vitiani L., Zeuner A., Pallini R., Lotti F., Sette G., Pilozzi E., Larocca L.M., Peschle C., De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 2006, 13:1238-1241.
5. Shafee N., Smith C.R., Wei S., Kim Y., Mills G.B., Hortobagyi G.N., Stanbridge E.J., Lee E.Y. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Res. 2008, 68:3243-3250.
6. Shervington A., Lu C. Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest. 2008, 26:535-542.
7. Summy J.M., Gallick G.E. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003, 22:337-358.
8. Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell 2000, 100:293-296.
9. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13:513-609.
10. Guarino M. Src signaling in cancer invasion. J. Cell. Physiol. 2010, 223:14-26.
11. Biscardi J.S., Ishizawar R.C., Silva C.M., Parsons S.J. Tyrosine kinase signaling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res. 2000, 2:203-210.
12. Ishizawar R., Parsons S.J. C-Src and cooperating partners in human cancer. Cancer Cell 2004, 6:209-214.
13. Wheeler D.L., Iida M., Dunn E.F. The role of Src in solid tumors. Oncologist 2009, 14:667-678.
14. Omri B., Crisanti P., Marty M.C., Alliot F., Fagard R., Molina T., Pessac B. The Lck tyrosine kinase is expressed in brain neurons. J. Neurochem. 1996, 67:1360-1364.
15. Cotton P.C., Brugge J.S. Neural tissues express high levels of the cellular src gene product pp60c-src. Mol. Cell. Biol. 1983, 3:1157-1162.
16. Du J., Bernasconi P., Clauser K.R., Mani D.R., Finn S.P., Beroukhim R., Burns M., Julian B., Peng X.P., Hieronymus H., Maglathlin R.L., Lewis T.A., Liau L.M., Nghiemphu P., Mellinghoff I.K., Louis D.N., Loda M., Carr S.A., Kung A.L., Golub T.R. Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nat. Biotechnol. 2009, 27:77-83.
17. Dey N., Crosswell H.E., De P., Parsons R., Peng Q., Su J.D., Durden D.L. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res. 2008, 68:1862-1871.
18. Chiou S.H., Kao C.L., Chen Y.W., Chien C.S., Hung S.C., Lo J.F., Chen Y.J., Ku H.H., Hsu M.T., Wong T.T. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 2008, 3:e2090.
19. Wang J., Wakeman T.P., Lathia J.D., Hjelmeland A.B., Wang X.F., White R.R., Rich J.N., Sullenger B.A. Notch promotes radioresistance of glioma stem cells. Stem cells 2010, 28:17-28.
20. Rich J.N. Cancer stem cells in radiation resistance. Cancer Res. 2007, 67:8980-8984.
21. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 2006, 5:67.
22. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
23. Zhang M., Atkinson R.L., Rosen J.M. Selective targeting of radiation-resistant tumor-initiating cells. Proc. Natl. Acad. Sci. USA 2010, 107:3522-3527.
24. Campos B., Wan F., Farhadi M., Ernst A., Zeppernick F., Tagscherer K.E., Ahmadi R., Lohr J., Dictus C., Gdynia G., Combs S.E., Goidts V., Helmke B.M., Eckstein V., Roth W., Beckhove P., Lichter P., Unterberg A., Radlwimmer B., Herold-Mende C. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin. Cancer Res. 2010, 16:2715-2728.
25. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., Hahn W.C., Ligon K.L., Louis D.N., Brennan C., Chin L., DePinho R.A., Cavenee W.K. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007, 21:2683-2710.
26. Mercer R.W., Tyler M.A., Ulasov I.V., Lesniak M.S. Targeted therapies for malignant glioma: progress and potential. BioDrugs 2009, 23:25-35.
27. de Groot J., Milano V. Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J. Neurooncol. 2009, 95:151-163.
28. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R.D., Engh J., Iwama T., Kunisada T., Kassam A.B., Pollack I.F., Park D.M. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009, 28:3949-3959.